Many human cancers are more prevalent in men than women. This disparity is not fully explained by differences in key risk factor exposures, which suggests a possible genetic cause. Recent research has reported a link between loss of the Y chromosome (LoY) and increased incidence of non-haematological cancers. Using data from The Cancer Genome Atlas, I conducted an integrated, multi-‘omic analysis of Y chromosome methylation and copy number aberrations in three different cancers – colon, head and neck and kidney. My results indicate that aberrant methylation of the Y chromosome is common in all three cancer types. Hyper-methylation occurs in short, discrete regions, interspersed among wider regions of more general hypo-methylation. I also ...
PhDFollicular Lymphoma (FL) is a common B cell Non-Hodgkin Lymphoma with a median survival of 8-10 y...
Deregulation of promoter methylation is a well-defined phenomenon in prostate cancer (PCa). This doe...
Immunotherapy is a valuable approach to target tumour cells by stimulating the body’s adaptive immun...
Aberrant DNA methylation is a well known characteristic of cancer genomes. It can be used as a way o...
The 5-year survival rate of head and neck squamous cell carcinoma (HNSCC) has remained at ~50% for o...
Aberrant DNA methylation is a well known characteristic of cancer genomes. It can be used as a way o...
While 10-15% of the human genome is composed of heterochromatic DNA, these regions are not included ...
While 25% of ovarian cancer (OVCA) cases are due to inherited factors, most of the genetic risk rema...
While 25% of ovarian cancer (OVCA) cases are due to inherited factors, most of the genetic risk rema...
Epigenetic modification is another mechanism involved in the cancer development besides classic muta...
While 25% of ovarian cancer (OVCA) cases are due to inherited factors, most of the genetic risk rema...
While 25% of ovarian cancer (OVCA) cases are due to inherited factors, most of the genetic risk rema...
Radiotherapy continues to be a primary modality in the treatment of cancer. DNA damage induced by ra...
Increased knowledge into the molecular pathways disrupted in tumours has led to the development of v...
While 25% of ovarian cancer (OVCA) cases are due to inherited factors, most of the genetic risk rema...
PhDFollicular Lymphoma (FL) is a common B cell Non-Hodgkin Lymphoma with a median survival of 8-10 y...
Deregulation of promoter methylation is a well-defined phenomenon in prostate cancer (PCa). This doe...
Immunotherapy is a valuable approach to target tumour cells by stimulating the body’s adaptive immun...
Aberrant DNA methylation is a well known characteristic of cancer genomes. It can be used as a way o...
The 5-year survival rate of head and neck squamous cell carcinoma (HNSCC) has remained at ~50% for o...
Aberrant DNA methylation is a well known characteristic of cancer genomes. It can be used as a way o...
While 10-15% of the human genome is composed of heterochromatic DNA, these regions are not included ...
While 25% of ovarian cancer (OVCA) cases are due to inherited factors, most of the genetic risk rema...
While 25% of ovarian cancer (OVCA) cases are due to inherited factors, most of the genetic risk rema...
Epigenetic modification is another mechanism involved in the cancer development besides classic muta...
While 25% of ovarian cancer (OVCA) cases are due to inherited factors, most of the genetic risk rema...
While 25% of ovarian cancer (OVCA) cases are due to inherited factors, most of the genetic risk rema...
Radiotherapy continues to be a primary modality in the treatment of cancer. DNA damage induced by ra...
Increased knowledge into the molecular pathways disrupted in tumours has led to the development of v...
While 25% of ovarian cancer (OVCA) cases are due to inherited factors, most of the genetic risk rema...
PhDFollicular Lymphoma (FL) is a common B cell Non-Hodgkin Lymphoma with a median survival of 8-10 y...
Deregulation of promoter methylation is a well-defined phenomenon in prostate cancer (PCa). This doe...
Immunotherapy is a valuable approach to target tumour cells by stimulating the body’s adaptive immun...